Penrhos Bio joins with Pro3dure Medical

Penrhos Bio joins with Pro3dure Medical


Unilever and Innova Partnerships one step closer to
self-cleaning surfaces

Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials

Through our licence partner in the dental field, (Jernberg Biotechnology), Penrhos Bio has formed a new and exciting partnership with Pro3dure Medical. Pro3dure are world leading in 3D printing technology for medical devices, including in the dental space.

Working closely with Penrhos Bio, and leveraging the R&D expertise of our technical team in Unilever, Pro3dure are developing and launching their new product, MIS, which incorporates our Remora™️ technology.

Quote from Richard Hammond CEO of Penrhos Bio:

We are thrilled to be working with our colleagues at Pro3dure Medical to combine the power of  Remora™️ technology with their world leading expertise in material development. The result is a completely novel way of inhibiting the formation of harmful multispecies biofilms in their MIS products. Remora™️  is inspired by the natural biology certain seaweeds have developed which enables them to block communication between microorganisms. The result is a surface that remains clean and free of biofilms. Backed by Unilever, we have proven efficacy in a wide range of applications, and we are really excited to bring this benefit into dental markets through the innovation of Pro3dure, an ideal partnership. 

Penrhos Bio Launch Series A raise

Penrhos Bio is currently undertaking a Series A investment raise. This investment will accelerate our regulatory roadmap for the Remora™ technology and unlocks a number of higher value markets such as marine fouling and human healthcare…

Read More »